About LieffCabraser

"One of the nation's premier plaintiffs firms," Lieff Cabraser has 120 lawyers in San Francisco, New York, Nashville, and Munich. We have a widely diversified practice successfully representing plaintiffs in the fields of personal injury and mass torts, securities and financial fraud, employment discrimination and unlawful employment practices, product defect, consumer protection, antitrust, environmental and toxic exposures, False Claims Act, digital privacy and data security, and civil and human rights. Our clients include individuals, classes and groups of people, businesses, and public and private entities.

Lawsuits Mount Against Devereux Behavioral Health Over Allegations of Resident Abuse

Report features extensive commentary from Lieff Cabraser partner Annika K. Martin, who represents the plaintiffs in the proposed minor abuse class action against Devereux Behavioral Health As reported by Law.com (subscription), lawsuits against the Devereux Foundation (a/k/a Devereux Advanced Behavioral Health) are growing in number over allegations that the nonprofit, specializing

2022-05-04T23:11:16+00:00May 4th, 2022|Sexual Abuse|

Juul And Altria’s Latest Attempt to Dismiss Teen Vaping Lawsuit Fails

As reported by Law360 (subscription), on May 2, 2022, U.S. District Judge William H. Orrick of the Northern District of California issued an order denying the meaningful portions of the latest wave of defendants’ motions to dismiss claims from a teen’s lawsuit alleging that e-cigarette manufacturer Juul and its part-owner Altria

2024-01-29T16:51:10+00:00May 3rd, 2022|Consumer Fraud, Personal Injury|

Thirteen Lieff Cabraser Attorneys Recognized as Lawdragon “500 Leading Plaintiff Consumer Lawyers” for 2022

Lawdragon has published its list of the “500 Leading Plaintiff Consumer Lawyers in America” for 2022, an honor roll that includes Lieff Cabraser partners Donald C. Arbitblit, Kenneth S. Byrd, Elizabeth J. Cabraser, Mark P. Chalos, Paulina do Amaral, Steven E. Fineman, Wendy R. Fleishman, Rachel Geman, Lexi J. Hazam, Richard M. Heimann, Sarah R. London, Annika K. Martin, and Robert J. Nelson. The Lawdragon consumer

2022-04-19T22:08:04+00:00April 19th, 2022|Awards, Firm News|

Plaintiffs Defeat Ford’s Dismissal Attempt in Faulty Truck Brakes Litigation

As reported by Law360, on April 12, 2022, U.S. District Judge Gershwin A. Drain of the Eastern District of Michigan ruled in favor of plaintiffs in refusing Ford’s attempt to dismiss the litigation filed on behalf of hundreds of Ford F-150 pickup truck owners who have experienced sudden and dangerous brake failures in their vehicles.

2022-04-12T20:01:53+00:00April 12th, 2022|Car Accidents & Recalls, Firm News|

SF Opioid Claims Move Forward, Despite Big Pharma’s Ongoing Attempts to Dismiss

As reported by Law360, on April 8, 2022, U.S. District Judge Charles R. Breyer of the Northern District of California issued a ruling that Teva Pharmaceuticals, Allergan, Anda Inc. and other major pharmaceutical companies and distributors allegedly responsible for the manufacturing, transmission, and sale of dangerous, highly addictive and often lethal prescription opioids such as Oxycontin and fentanyl,

2022-04-11T19:11:20+00:00April 11th, 2022|Firm News, Prescription Drug Injuries|

David Rudolph to Discuss Ethical Considerations in Class Actions at 25th Annual ABA National Institute on Class Actions

Lieff Cabraser partner David Rudolph will speak at the American Bar Association’s 25th Annual National Institute on Class Actions on Wednesday, April 13th, 2022 at 10:00 am CT at The Driskill Hotel in Austin, Texas. David will be featured on the panel “Don’t Get Bucked by the Mechanical Bull: Holding onto Adversarial Ethics While Riding Innovations.” The panel

2022-04-11T20:54:24+00:00April 11th, 2022|Firm News|

DOJ Antitrust Division Announces it Will Now Require Leniency Applicants to Pay Restitution to Victims

Before receiving a final leniency letter, applicants must now actually pay restitution to the victims of the misconduct The Antitrust Division of the DOJ today announced updates to one of its primary enforcement tools, the offender leniency program, and issued a revised set of plain-language answers to frequently asked questions (FAQs) relating to the program. The

2022-04-05T18:39:19+00:00April 5th, 2022|Antitrust|